Psoríase Online - INTERNET MÉDICA

■ Neurodegenerative disorders, bullos pemhigoid and psoriasis: a comparative study in ethnic Poles indicate that Parkinson´s disease is more relevant to bullos pemphigoid

Paweł Bartkiewicz, Justyna Gornowicz-Porowska, Paweł P. Pietkiewicz et al

Postepy Dermatol Alergol. 2017 Feb; 34(1): 42–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329105/

■ Under-treatment of patients with moderate to severe psoriasis in the United States: analysis of medication usage with health plan data

April W. Armstrong, J. Will Koning, Simon Rowse et al

Dermatol Ther (Heidelb) 2017 Mar; 7(1): 97–109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336424/

■ Cognitive impairment in patients with severe psoriasis

Luiza Marek-Józefowicz, Marcin Jaracz, Waldemar Placek et al

Postepy Dermatol Alergol. 2017 Apr; 34(2): 120–125

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420603/

■ Prevalencia de la enfermedad celíaca en los pacientes con psoriasis

C Rafaelli, N Poggio, V Neglia et al

Dermatologia Argentina 2017, vol 23 (1): 23-28

http://www.dermatolarg.org.ar/index.php/dermatolarg/article/view/1563/895

■ Clinical evaluation of omega-3 fatty acids in psoriasis

M Adil, P K Singh, K Maheshwari

Dermatol Rev/Przegl Dermatol 2017, vol 104:314-323

https://www.termedia.pl/Clinical-evaluation-of-omega-3-fatty-acids-in-psoriasis,56,30259,1,1.html

■ Psoriasis, psoriatic arthritis, and thyroid autoimmunity

Ruffilli I, Ragusa F, Benvenga S, Vita R, Antonelli A, Fallahi P, Ferrari SM.

Front Endocrinol (Lausanne). 2017 , vol 8:13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474675/

■ Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis

Zarif K. Jabbar-Lopez, Zenas Z.N. Yiu, Victoria Ward et al

J Invest Dermatol. 2017, vol 137(8): 1646–1654

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519491/

■ Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials

Rungapiromnan, Z.Z.N. Yiu, R.B. Warren, C.E.M. Griffiths, D.M. Ashcroft

Br J Dermatol. 2017 vol 176(4): 890–901

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412670/

■ Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy

M Agozzino, C Noal, F Lacarruba, M Ardigó

Psoriasis: Targets and Therapy 2016, vol 6: 27-34

https://www.dovepress.com/monitoring-treatment-response-in-psoriasis-current-perspectives-on-the-peer-reviewed-fulltext-article-PTT

■ Local effects of adipose tissue in psoriasis and psoriatic arthritis

I L Kruglikov, U Wollina

Psoriasis: Targets and Therapy 2016, vol 6: 17-25

https://www.dovepress.com/local-effects-of-adipose-tissue-in-psoriasis-and-psoriatic-arthritis-peer-reviewed-fulltext-article-PTT

■ Current knowledge on psoriasis and autoimmune diseases

N Ayala-Fontánez, D C Soler, T S McCormick

Psoriasis: Targets and Therapy 2016, vol 6: 7-32

https://www.dovepress.com/current-knowledge-on-psoriasis-and-autoimmune-diseases-peer-reviewed-fulltext-article-PTT

■ Excimer laser for the treatment of psoriasis: safety, efficacy and patient acceptability

M Abrouk, E Levin, M Brodsky et al

Psoriasis: Targets and Therapy 2016, vol 6: 165-173

https://www.dovepress.com/excimer-laser-for-the-treatment-of-psoriasis-safety-efficacy-and-patie-peer-reviewed-fulltext-article-PTT

■ Tacrolimus for the management of psoriasis: clinical utility and place in therapy

N Malecic, H Young

Psoriasis: Targets and Therapy 2016, vol 6: 153-163

https://www.dovepress.com/tacrolimus-for-the-management-of-psoriasis-clinical-utility-and-place–peer-reviewed-fulltext-article-PTT

■ Pustular psoriasis: pathophysiology and current treatment perspectives

K E Benjegerdes, K Hyde, D Kivelevitch, B Mansouri

Psoriasis: Targets and Therapy 2016, vol 6: 131-163

https://www.dovepress.com/pustular-psoriasis-pathophysiology-and-current-treatment-perspectives-peer-reviewed-fulltext-article-PTT

■ Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management

M V Cannizzaro, C Franceschini, M Esposito et AL

Psoriasis: Targets and Therapy 2016, vol 6: 35-40

https://www.dovepress.com/hepatitis-b-reactivation-in-psoriasis-patients-treated-with-anti-tnf-a-peer-reviewed-fulltext-article-PTT

■ Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges

L el Hayderi, F Colson, B Dezfoulian, A F Nikkels

Psoriasis: Targets and Therapy 2016, vol 6: 145-151

https://www.dovepress.com/herpes-zoster-in-psoriasis-patients-undergoing-treatment-with-biologic-peer-reviewed-fulltext-article-PTT

■ Prevalence of acute and chronic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infections events in psoriasis complicated by active psoriatic arthritis

D Colombo, S Chimenti, P A Grossi et al

Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 1-7

https://www.dovepress.com/prevalence-of-acute-and-chronic-viral-seropositivity-and-characteristi-peer-reviewed-fulltext-article-CCID

■ Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review incluind GRADE assessment

A Atwan, J R Ingram, R Abbot et AL

British Journal of Dermatology 2016, vol 175 (5): 83-881

http://onlinelibrary.wiley.com/doi/10.1111/bjd.14676/full

■ Psoriasis in children

R Pinson, B Sotoodian, L Fiorillo

Psoriasis: Targets and Therapy 2016, vol 6: 121-129

https://www.dovepress.com/psoriasis-in-children-peer-reviewed-fulltext-article-PTT

■ Combining biologic and phototherapy for psoriasis: safety, efficacy, and patient acceptability

B Farahnik, V Patel, K Berokhim et al

Psoriasis: Targets and Therapy 2016, vol 6: 105-111

https://www.dovepress.com/combining-biologic-and-phototherapy-treatments-for-psoriasis-safety-ef-peer-reviewed-fulltext-article-PTT

■ Erythordermic psoriasis: pathophysiology and current treatment perspectives

R K Sing, K M Lee, D Ucmark et al

Psoriasis: Targets and Therapy 2016, vol 6: 93-10

https://www.dovepress.com/erythrodermic-psoriasis-pathophysiology-and-current-treatment-perspect-peer-reviewed-fulltext-article-PTT

■ Psoriasis and inflammatory bowel disease: links and risks

C Vlachos, G Gaitanis, K H Katsanos et AL

Psoriasis: Targets and Therapy 2016, vol 6: 73-92

https://www.dovepress.com/psoriasis-and-inflammatory-bowel-disease-links-and-risks-peer-reviewed-fulltext-article-PTT

■ Psoriasis and smoking: links and risks

L Naldi

Psoriasis: Targets and Therapy 2016, vol 6: 65-71

https://www.dovepress.com/psoriasis-and-smoking-links-and-risks-peer-reviewed-fulltext-article-PTT

■ Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects

S M Franken, C L Vierstra, T Rstemeyer

Psoriasis: Targets and Therapy 2016, vol 6: 55-64

https://www.dovepress.com/improving-access-to-home-phototherapy-for-patients-with-psoriasis-curr-peer-reviewed-fulltext-article-PTT

■ Assessment and monitoring of biologic drug adverse events in patients with psoriasis

T Hanley, M Handford, D Lavery, Z Z N Yiu

Psoriasis: Targets and Therapy 2016, vol 6: 41-54

https://www.dovepress.com/assessment-and-monitoring-of-biologic-drug-adverse-events-in-patients–peer-reviewed-fulltext-article-PTT

■ Management of scalp psoriasis: current perspectives

K Blakely, M Gooderham

Psoriasis: Targets and Therapy 2016, vol 6: 33-40

https://www.dovepress.com/management-of-scalp-psoriasis-current-perspectives-peer-reviewed-fulltext-article-PTT

■ Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?

A Landriscina, A J Friedman

Psoriasis: Targets and Therapy 2016, vol 6: 1-5

https://www.dovepress.com/integrating-lifestyle-focused-approaches-into-psoriasis-care-improving-peer-reviewed-fulltext-article-PTT

■ The psychosocial impact of acne, vitiligo, and psoriasis: a review

C M Nguyen, K Beroukhim, M J Danesh et al

Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 383-392

https://www.dovepress.com/the-psychosocial-impact-of-acne-vitiligo-and-psoriasis-a-review-peer-reviewed-fulltext-article-CCID

■ New oral therapies for psoriasis: a comprehensive review

Gary Goldenberg, Julien Lanoue, Joanna Dong

J Clin Aesthet Dermatol. 2016 Aug; 9(8): 25–28

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022993/

■ Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation

Bárbara Isabel Roque Cunha Ferreira, José Luís Pio Da Costa Abreu, José Pedro Gaspar Dos Reis, Américo Manuel Da Costa Figueiredo

J Clin Aesthet Dermatol. 2016 Jun; 9(6): 36–43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928455/

■ Updates on psoriasis and cutaneos oncology: proceedings from the 2016 MaiDerm Meeting based on presentations by

George Martin, Bruce E. Strober, Craig L. Leonardi, Joel M. Gelfand, Andrew Blauvelt, Arthur Kavanaugh, Linda Stein Gold, Brian Berman, Ted Rosen, Eggert Stockfleth

J Clin Aesthet Dermatol. 2016 Sep; 9(9 Suppl 1): S5–S29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077303/

■ Oral apremilast for the treatment of plaque psoriasis

James Q. Del Rosso, Leon Kircik

J Clin Aesthet Dermatol. 2016 Sep; 9(9): 43–48

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110328/

■ Study of serum levels and skin expression of S100B protein in psoriasis.

Salem, Samar Abdallah M. et al.

An. Bras. Dermatol., June 2017, vol.92, no.3, p.323-328

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300323&lng=pt&nrm=iso

■ Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis

Vasconcellos, Jaqueline Barbeito de et al.